Wilma L. Lingle

15.1k citations

102 papers · 7.4k indexed · 3 hit papers · h-index 44

Molecular Biology top 2%
Oncology top 0.5%
Cancer Research top 0.5%
Cell Biology top 0.5%
Genetics top 1%

Co-authors: Jeffrey L. Salisbury James N. Ingle Vera J. Suman Daniel W. Visscher Carol Reynolds Antonino B. D’Assoro Edith A. Perez Vivian Negron
Topics: HER2/EGFR in Cancer Research (26 papers)Microtubule and mitosis dynamics (23 papers)Cancer-related Molecular Pathways (14 papers)
Cited by: Cancer Research Oncology Cell Biology
Journals: New England Journal of Medicine Proceedings of the National Academy of Sciences Journal of Biological Chemistry
Partner nations: United States Italy China

In The Last Decade

Wilma L. Lingle

102 papers receiving 7.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Benign Breast Disease and the Risk of Breast Cancer

2005 628 citations Lynn C. Hartmann, Wilma L. Lingle et al. profile →
FKBP51 Affects Cancer Cell Response to Chemotherapy by Negatively Regulating Akt

2009 568 citations Huadong Pei, Liang Li et al. Cancer Cell profile →
Pharmacogenetics of Tamoxifen Biotransformation Is Associated With Clinical Outcomes of Efficacy and Hot Flashes

2005 567 citations Vera J. Suman, Daniel W. Visscher et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Wilma L. Lingle

Since Specialization

Citations

This map shows the geographic impact of Wilma L. Lingle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wilma L. Lingle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wilma L. Lingle more than expected).

Fields of papers citing papers by Wilma L. Lingle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wilma L. Lingle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wilma L. Lingle. The network helps show where Wilma L. Lingle may publish in the future.

Co-authorship network of co-authors of Wilma L. Lingle

This figure shows the co-authorship network connecting the top 25 collaborators of Wilma L. Lingle. A scholar is included among the top collaborators of Wilma L. Lingle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wilma L. Lingle. Wilma L. Lingle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact of c-MYC Protein Expression on Outcome of Patients with Early-Stage HER2+ Breast Cancer Treated with Adjuvant Trastuzumab NCCTG (Alliance) N9831 2013 ·Clinical Cancer Research ·Amylou C. Dueck,Monica M. Reinholz,Xochiquetzal J. Geiger,Kathleen Tenner,Karla V. Ballman,Robert B. Jenkins,Darren Riehle,Beiyun Chen,Ann E. McCullough,Nancy E. Davidson,Silvana Martino,George W. Sledge,Peter A. Kaufman,Leila A. Kutteh,Julie R. Gralow,Lyndsay N. Harris,James N. Ingle,Wilma L. Lingle,Edith A. Perez	19
2	Impact of PTEN Protein Expression on Benefit From Adjuvant Trastuzumab in Early-Stage Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer in the North Central Cancer Treatment Group N9831 Trial 2013 ·Journal of Clinical Oncology ·Edith A. Perez,Amylou C. Dueck,Ann E. McCullough,Beiyun Chen,Xochiquetzal J. Geiger,Robert B. Jenkins,Wilma L. Lingle,Nancy E. Davidson,Silvana Martino,Peter A. Kaufman,Leila A. Kutteh,George W. Sledge,Lyndsay N. Harris,Julie R. Gralow,Monica M. Reinholz	89
3	The mitotic kinase Aurora-A promotes distant metastases by inducing epithelial-to-mesenchymal transition in ERα+ breast cancer cells 2013 ·Oncogene ·Antonino B. D’Assoro,(unknown),Cosima Quatraro,Angela Amato,Mateusz Opyrchal,Alexey A. Leontovich,Yasuhiro Ikeda,Seiga Ohmine,Wilma L. Lingle,Vera J. Suman,(unknown),Ianko Iankov,Aldo Di Leonardo,(unknown),Amy C. Degnim,(unknown),James A. McCubrey,James N. Ingle,(unknown),Evanthia Galanis	101
4	Cytokeratin-19 and Mammaglobin Gene Expression in Circulating Tumor Cells from Metastatic Breast Cancer Patients Enrolled in North Central Cancer Treatment Group Trials, N0234/336/436/437 2011 ·Clinical Cancer Research ·Monica M. Reinholz,(unknown),Kathleen Tenner,David W. Hillman,Amylou C. Dueck,Timothy J. Hobday,Donald W. Northfelt,Alvaro Moreno‐Aspitia,Vivek Roy,Betsy LaPlant,Jake Allred,Philip J. Stella,Wilma L. Lingle,Edith A. Perez	45
5	HSulf-1 Modulates FGF2- and Hypoxia-Mediated Migration and Invasion of Breast Cancer Cells 2011 ·Cancer Research ·Ashwani Khurana,Peng Liu,Pasquale Mellone,Laura Lorenzon,Bruno Vincenzi,Kaustubh Datta,Bo Yang,Robert J. Linhardt,Wilma L. Lingle,Jeremy Chien,Alfonso Baldi,Viji Shridhar	46
6	Control of Centrin Stability by Aurora A 2011 ·PLoS ONE ·(unknown),Tammy M. Greenwood,Vivian Negron,Amy K. Bruzek,Jeffrey L. Salisbury,Wilma L. Lingle	23
7	Expression profiling of formalin-fixed paraffin-embedded primary breast tumors using cancer-specific and whole genome gene panels on the DASL®platform 2010 ·BMC Medical Genomics ·Monica M. Reinholz,Jeanette E. Eckel‐Passow,S. Keith Anderson,Yan W. Asmann,Michael A. Zschunke,Ann L. Oberg,Ann E. McCullough,Amylou C. Dueck,Beiyun Chen,Craig April,Eliza Wickham‐Garcia,Robert B. Jenkins,Julie M. Cunningham,Jin Jen,Edith A. Perez,Jian-Bing Fan,Wilma L. Lingle	11
8	Aromatase immunoreactivity is increased in mammographically dense regions of the breast 2010 ·Breast Cancer Research and Treatment ·Celine M. Vachon,Hironobu Sasano,Karthik Ghosh,Kathleen R. Brandt,David Watson,Carol Reynolds,Wilma L. Lingle,Paul E. Goss,Rong Li,Sarah E. Aiyar,Christopher G. Scott,V. Shane Pankratz,Richard J. Santen,James N. Ingle	43
9	Comparison of Central HER2 Testing With Quantitative Total HER2 Expression and HER2 Homodimer Measurements Using a Novel Proximity-Based Assay 2010 ·American Journal of Clinical Pathology ·Weidong Huang,Monica M. Reinholz,Jodi Weidler,(unknown),Agnès Paquet,Jeannette M. Whitcomb,Wilma L. Lingle,Robert B. Jenkins,Beiyun Chen,Jeffrey Larson,(unknown),Thomas Sherwood,Michael Bates,Edith A. Perez	34
10	Specific Overexpression of Cyclin E·CDK2 in Early Preinvasive and Primary Breast Tumors in Female ACI Rats Induced by Estrogen 2010 ·Hormones and Cancer ·S. John Weroha,Wilma L. Lingle,(unknown),Sara Antonia Li,Jonathan J. Li	13
11	Applications of Cellular Systems Biology in Breast Cancer Patient Stratification and Diagnostics 2009 ·Combinatorial Chemistry & High Throughput Screening ·Rebecca J. Critchley-Thorne,Steven V. Miller,D. Lansing Taylor,Wilma L. Lingle	11
12	Breast cancer and aneusomy 17: implications for carcinogenesis and therapeutic response 2009 ·The Lancet Oncology ·Monica M. Reinholz,Amy K. Bruzek,Daniel W. Visscher,Wilma L. Lingle,Matthew Schroeder,Edith A. Perez,Robert B. Jenkins	77
13	Deficiencies in Chfr and Mlh1 synergistically enhance tumor susceptibility in mice 2009 ·Journal of Clinical Investigation ·Zheng Fu,Kevin M. Regan,Lizhi Zhang,Michael H. Muders,Stephen N. Thibodeau,Amy J. French,Yanhong Wu,Scott H. Kaufmann,Wilma L. Lingle,Junjie Chen,Donald J. Tindall	26
14	FKBP51 Affects Cancer Cell Response to Chemotherapy by Negatively Regulating Aktbreakdown → 2009 ·Cancer Cell ·Huadong Pei,Liang Li,Brooke L. Fridley,Gregory D. Jenkins,Krishna R. Kalari,Wilma L. Lingle,Gloria M. Petersen,Zhenkun Lou,Liewei Wang	568
15	Racial Disparity in Breast Cancer and Functional Germ Line Mutation in Galectin-3 (rs4644): A Pilot Study 2008 ·Cancer Research ·Vitaly Balan,Pratima Nangia‐Makker,Ann G. Schwartz,Young Suk Jung,Larry Tait,Victor Hogan,Tirza Raz,Yi Wang,Zeng Quan Yang,Gen Sheng Wu,Yongjun Guo,Huixiang Li,Judith Abrams,Fergus J. Couch,Wilma L. Lingle,Ricardo V. Lloyd,Stephen P. Ethier,Michael A. Tainsky,Avraham Raz	49
16	Folate receptor overexpression is associated with poor outcome in breast cancer 2007 ·International Journal of Cancer ·Lynn C. Hartmann,Gary L. Keeney,Wilma L. Lingle,Teresa J. Christianson,Bindu Varghese,David W. Hillman,Ann L. Oberg,Philip S. Low	197
17	Deregulation of the Centrosome Cycle and the Origin of Chromosomal Instability in Cancer 2006 ·Advances in experimental medicine and biology ·Wilma L. Lingle,(unknown),Jeffrey L. Salisbury	57
18	Endolithic Thraustochytrid Marine Fungi from Planted Shell Fragments 1992 ·Mycologia ·David Porter,Wilma L. Lingle	20
19	Localization of Bioluminescent Tissues During Basidiocarp Development in Panellus Stypticus 1990 ·Mycologia ·Dennis J. O’Kane,Wilma L. Lingle,David Porter,John E. Wampler	12
20	Spectral Analysis of Bioluminescence of Panellus Stypticus 1990 ·Mycologia ·Dennis J. O’Kane,Wilma L. Lingle,David Porter,John E. Wampler	21

About Wilma L. Lingle

Wilma L. Lingle is a scholar working on Oncology, Cell Biology and Cancer Research, having authored 102 papers that have together received 7.4k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (26 papers), Microtubule and mitosis dynamics (23 papers) and Cancer-related Molecular Pathways (14 papers). The work is most often cited by research in Cancer Research (2.0k citations), Oncology (3.1k citations) and Cell Biology (1.7k citations). Wilma L. Lingle has collaborated with scholars based in United States, Italy and China. Frequent co-authors include Jeffrey L. Salisbury, James N. Ingle, Vera J. Suman, Daniel W. Visscher, Carol Reynolds, Antonino B. D’Assoro, Edith A. Perez, Vivian Negron, W Lütz and Matthew P. Goetz. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact